Journals / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2013 / Cilt: 26 - Sayı: 4

Lityum kesilmesinden sonra 72 ay devam eden nefrojenik diabetes insipidus: Olgu sunumu

Seventy-two Months Ongoing Nephrogenic Diabetes Insipidus after Discontinuation of Lithium: A Case Report

Pages
398–401
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a case of nephrogenic diabetes insipidus lasting 72 months after the discontinuation of short term lithium usage and the diagnosis and treatment process of this patient

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lithium is a drug commonly used in mood disorders.
📊
Key Findings & Data:This common usage has brought with it a better recognition of its common side effects.
💡
Conclusion & Impact:We present a case of nephrogenic diabetes insipidus lasting 72 months after the discontinuation of short term lithium usage and the diagnosis and treatment process of this patient
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lithium is a drug commonly used in mood disorders. This common usage has brought with it a better recognition of its common side effects. Side effects of lithium on kidney is one of the most frequent and one of them is nephrogenic diabetes insipidus (NDI). NDI is characterized by polyuria and polydipsia; it develops due to the effect of lithium on sodium and water absorbtion at the level of the collecting tubules causing deterioration in the urinary concentrating ability. Most of NDI cases due to lithium treatment resolve spontaneously after discontinuation of lithium. Recovery of NDI cases due to long-term usage of lithium may take longer. We present a case of nephrogenic diabetes insipidus lasting 72 months after the discontinuation of short term lithium usage and the diagnosis and treatment process of this patient

Özet

Lityum, duygudurum bozukluklarında sık kullanılan bir ilaçtır. Bu sık kullanım, lityumun yan etkilerinin daha iyi tanınmasını sağlamıştır. Lityumun böbrek üzerindeki yan etkileri en sık karşılaştığımız yan etkilerdendir. Bu yan etkilerden biri de nefrojenik diabetes insipidustur (NDİ). Poliüri ve polidipsi ile karakterize olan NDİ, lityumun toplayıcı tübüller seviyesinde su ve sodyum emilimini etkilemesine bağlı olarak, böbreğin idrarı konsantre etme yeteneğinin bozulması sonucu gelişmektedir. NDİ gözlenen çoğu olgu, lityum tedavisinin kesilmesinin ardından kendiliğinden düzelir. Uzun süre lityum kullanımına bağlı NDİ vakalarının düzelmesi daha uzun süre alabilir. Biz de bu olgu sunumunda, kısa süreli lityum kullanımına bağlı gelişen ve 72 ay boyunca devam eden bir NDİ hastasını, bu hastanın tanı ve tedavi sürecini sunmayı planladık

🔖

Cite This Article

ELBOĞA, G., ÜNAL, A., ALPAK, G., ELBOĞA, U., ÖZKAYA, M., SAVAŞ, H., BÜLBÜL, F. (2013). Lityum kesilmesinden sonra 72 ay devam eden nefrojenik diabetes insipidus: Olgu sunumu. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 26 - Sayı: 4, 398–401. https://ajindex.com/articles/213981

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 1999; 21:449-456
  2. Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol 2008; 3:1324-1331
  3. Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long term lithium patients: continued surveillance needed. Eur Psychiatry 2001; 16:199-206
  4. Mizuno H, Sugiyama Y, Ohro Y, Imamine H, Kobayashi M, Sasaki S, Uchida S, Togari H. Clinical characteristics of eight patients with nephrogenic diabetes insipidus. Endocrine 2004; 24:55-59
  5. Blount MA, Sim JH, Zhou R, Martin CF, Lu W, Sands JM, Klein JD. Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment. Am J Physiol Renal Physiol 2010; 298:601-608
  6. Nielsen J, Kwon TH, Praetorius J, Kim YH, Frokiaer J, Knepper MA, Nielsen S. Segment-specific ENaC downregulation in kidney of rats with lithium induced NDI. Am J Physiol Renal Physiol 2003; 285:1198-1209
  7. Aron DC, Findling JW, Tyrrell JB. Hypothalamus and Pituitary. In Greenspan FS, Gardner DG (editors). Basic and Clinical Endocrinology. Sixth Ed. New York: McGraw-Hill Company, 2001, 155
  8. Kalenderoglu A, Ozen ME, Selek S, Savas E, Savas HA. Persistent nephrogenic diabetes insipidus after discontinuation of lithium: a case report. Düşünen Adam The Journal of Psychiatry and Neurological Sciences 2006; 19:50-54. (Turkish
  9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Ed. Washington: APA, 1994
  10. Guirguis AF, Taylor HC. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium therapy: report of a case and review of the literature. Endocr Pract 2000; 6:324-328
  11. Stone KA. Lithium induced nephrogenic diabetes insipidus. J Am Board Fam Pract 1999; 12:43-47
  12. Thompson CJ, France AJ, Baylis PH. Persistent nephrogenic diabetes insipidus following lithium therapy. Scott Med J 1997; 42:16-17
  13. Eustatia-Rutten CF, Tamsma JT, Meinders AE. Lithium-induced nephrogenic diabetes insipidus. Neth J Med 2001; 58:137-142.